Augmented Blood Pressure Variability in Hypertension Induced by Angiotensin II in Rats. 2016

Danfeng Jiang, and Mariko Tokashiki, and Hidetaka Hayashi, and Yukiko Kawagoe, and Kenji Kuwasako, and Kazuo Kitamura, and Johji Kato
Frontier Science Research Center, University of Miyazaki, Miyazaki, Japan;

BACKGROUND Augmented blood pressure (BP) variability is associated with cardiovascular diseases in some clinical conditions including hypertension. Drugs that effectively reduce BP variability need to be identified, while few animal models are currently available to study BP variability. Here, we report that hypertension induced by continuous infusion of angiotensin II (Ang II) was accompanied by increased BP variability in rats. METHODS Ang II was subcutaneously infused at a rate of 240 pmol/kg/min into male Wistar rats undergoing intraperitoneal implantation of a transmitter connected to an abdominal aortic catheter. BP was continuously monitored via a telemetry system before and after the Ang II infusion in a conscious, unrestrained condition. BP variability was evaluated by coefficient of variation (CV) of BP levels measured every 15 minutes. In addition, spontaneously hypertensive and Wistar-Kyoto rats (SHR and WKY) were subjected to the BP monitoring experiment at 15 weeks of age. RESULTS Both systolic and diastolic BP levels were significantly elevated following the Ang II infusion. Similarly, CVs of systolic and diastolic BP in the Ang II infusion group were significantly higher than in the vehicle group upon 1 and 2 weeks of the infusion. Meanwhile, CVs of systolic and diastolic BP of SHR were in a range similar to those of WKY despite significantly higher BP than in WKY. CONCLUSIONS Hypertension induced by the continuous infusion of Ang II was accompanied by augmented BP variability in rats, an effect assumed to be at least in part, independent of BP elevation.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D011918 Rats, Inbred SHR A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. Rats, Spontaneously Hypertensive,Rats, SHR,Inbred SHR Rat,Inbred SHR Rats,Rat, Inbred SHR,Rat, SHR,Rat, Spontaneously Hypertensive,SHR Rat,SHR Rat, Inbred,SHR Rats,SHR Rats, Inbred,Spontaneously Hypertensive Rat,Spontaneously Hypertensive Rats
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats

Related Publications

Danfeng Jiang, and Mariko Tokashiki, and Hidetaka Hayashi, and Yukiko Kawagoe, and Kenji Kuwasako, and Kazuo Kitamura, and Johji Kato
July 2017, European journal of pharmacology,
Danfeng Jiang, and Mariko Tokashiki, and Hidetaka Hayashi, and Yukiko Kawagoe, and Kenji Kuwasako, and Kazuo Kitamura, and Johji Kato
April 1993, The Tohoku journal of experimental medicine,
Danfeng Jiang, and Mariko Tokashiki, and Hidetaka Hayashi, and Yukiko Kawagoe, and Kenji Kuwasako, and Kazuo Kitamura, and Johji Kato
October 2009, Hypertension (Dallas, Tex. : 1979),
Danfeng Jiang, and Mariko Tokashiki, and Hidetaka Hayashi, and Yukiko Kawagoe, and Kenji Kuwasako, and Kazuo Kitamura, and Johji Kato
February 2020, Journal of hypertension,
Danfeng Jiang, and Mariko Tokashiki, and Hidetaka Hayashi, and Yukiko Kawagoe, and Kenji Kuwasako, and Kazuo Kitamura, and Johji Kato
January 1972, Annales medicinae experimentalis et biologiae Fenniae,
Danfeng Jiang, and Mariko Tokashiki, and Hidetaka Hayashi, and Yukiko Kawagoe, and Kenji Kuwasako, and Kazuo Kitamura, and Johji Kato
January 2023, Journal of the renin-angiotensin-aldosterone system : JRAAS,
Danfeng Jiang, and Mariko Tokashiki, and Hidetaka Hayashi, and Yukiko Kawagoe, and Kenji Kuwasako, and Kazuo Kitamura, and Johji Kato
March 1994, The American journal of physiology,
Danfeng Jiang, and Mariko Tokashiki, and Hidetaka Hayashi, and Yukiko Kawagoe, and Kenji Kuwasako, and Kazuo Kitamura, and Johji Kato
December 2022, Physiological research,
Danfeng Jiang, and Mariko Tokashiki, and Hidetaka Hayashi, and Yukiko Kawagoe, and Kenji Kuwasako, and Kazuo Kitamura, and Johji Kato
January 2016, Advanced biomedical research,
Danfeng Jiang, and Mariko Tokashiki, and Hidetaka Hayashi, and Yukiko Kawagoe, and Kenji Kuwasako, and Kazuo Kitamura, and Johji Kato
December 1990, Hearing research,
Copied contents to your clipboard!